This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

QlikTech Ranked Number One In KLAS Report, “Healthcare Analytics: Making Sense Of The Puzzle Pieces”

QlikTech, (NASDAQ: QLIK), a leader in user-driven Business Intelligence (BI), today announced that it has secured the highest overall ranking among enterprise BI and analytics vendors according to the “Healthcare Analytics: Making Sense of the Puzzle Pieces” 1 report published by KLAS, a research firm specializing in monitoring and reporting healthcare vendor performance. QlikTech’s overall ranking and rating is based on direct feedback from healthcare providers who have used the QlikView Business Discovery platform across their enterprise and measures software performance in areas such as product quality, implementation, and support.

With an overall rating of 85.7, QlikTech was noted for visual data discovery and ranked highest among other ranked vendors in areas such as overall satisfaction and ease of use. One customer reported that “It is easy to ingest the information in QlikView, and the data doesn’t have to be modeled and designed to the degree that the data in MicroStrategy and BusinessObjects does to provide insight.” Another customer said, “A key highlight of QlikView is that the users love it. I owe quite a substantial amount of the success of what we have been doing with business intelligence so far to the user adoption of QlikView. Essentially, after a few minutes, very nontechnical people can use QlikView, and they love using it.”

QlikTech also exceeded its competitors in key performance ratings for quality of training, product response time, delivery of new technology, and lives up to expectations. Among those ranked, it is the highest vendor ranked for money’s worth. Additionally, 100 percent of clients surveyed indicate that they would purchase QlikView again and that service and support “keeps promises”. According to a VP of a large health system, “… QlikView’s in-memory capabilities and nearly best-in-class visualization together offer an end-user experience we have been unable to duplicate with other tools. Our user satisfaction is very high. This is the best experience we have had with a BI product.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs